American Peptides BPC-157 + TB-500 Wolverine Blend: LOOT10 Pricing, Composition, COA and Catalog Guide

American Peptides lists its BPC-157 + TB-500 (Wolverine Blend) as a 20 mg research-peptide blend priced at $195, with displayed volume pricing that lowers the unit price to $181.35 for 3-4 units, $173.55 for 5-9, and $163.80 for 10+. The current catalog also provides a lot-matched COA and states that the material is for laboratory and research use only.

For the current promotion, use LOOT10 through American Peptides. The promotion is advertised as up to 30% off, so the exact savings should be checked at checkout rather than assumed to apply equally to every SKU or quantity tier.

What the American Peptides Wolverine Blend Actually Is

The most important starting point is that the Wolverine Blend is a combination of two distinct synthetic peptides, not a new single molecule.

American Peptides currently specifies the product as a 20 mg lyophilized peptide blend and identifies BPC-157 and TB-500 separately in its technical data. The product page lists BPC-157 at 15 amino acids and identifies TB-500 as a seven-amino-acid acetylated fragment, with the listed sequences provided for each component.

That distinction matters because the research literature on BPC-157, thymosin beta-4, and TB-500 does not automatically become combination evidence simply because two compounds are packaged together.

A current PubMed-indexed 2026 rat study examined BPC-157, TB-500, and their combination in an Achilles-tendon repair model. The authors reported some favorable histological findings in treated groups, but the combined group did not show additional benefit over the individual agents. Most importantly, the study was performed in rats, not humans, so its findings should be treated as exploratory preclinical evidence rather than proof of a human effect.

BPC-157: Where the Research Story Comes From

BPC-157 is a synthetic 15-amino-acid pentadecapeptide that has been investigated primarily in preclinical research. Contemporary reviews describe a research literature involving vascular signaling, angiogenesis, gastrointestinal models, connective-tissue biology, and other experimental systems.

The useful question for a research reader is not "does BPC-157 heal injuries?" The literature does not justify that kind of simple clinical conclusion. A better question is: what biological endpoints have researchers actually measured?

Recent reviews emphasize that BPC-157 remains translationally underdeveloped. One 2026 review notes the absence of an approved formulation, lack of a validated dosing regimen, and limited human clinical evidence.

That evidence gap is also reflected in current FDA material. FDA describes limited safety information for BPC-157 in the context of proposed compounded drug use and notes potential concerns involving immunogenicity and peptide-related impurities.

TB-500: Why the Thymosin Beta-4 Connection Matters

TB-500 creates a common source of confusion because online pages often slide between TB-500 and full-length thymosin beta-4 (Tβ4) as though they were interchangeable.

They are not the same material.

American Peptides currently lists TB-500 as a seven-amino-acid acetylated fragment, while the broader thymosin beta-4 literature includes research on the full-length 43-amino-acid protein.

That distinction is important when reading research. Evidence involving full-length Tβ4 may help explain biological context, but it does not automatically establish that a specific commercial TB-500 fragment produces the same result in the same model.

This distinction is also highlighted in the external American Peptides TB-500 research guide, which separates direct fragment evidence from parent-protein evidence and broader mechanistic literature. Read the TB-500 research guide.

There is genuine scientific history around Tβ4. Human studies have investigated full-length thymosin beta-4 in areas such as tissue repair, and a phase I study of recombinant human Tβ4 reported pharmacokinetic and safety observations in healthy volunteers. Those data are about Tβ4, however, and should not be presented as direct clinical validation of TB-500.

Why People Group BPC-157 and TB-500 Together

The pairing persists because the two compounds occupy overlapping research territory around tissue biology while having different molecular histories.

BPC-157 research frequently discusses vascular signaling, angiogenesis, endothelial biology, and soft-tissue models. TB-500 and Tβ4-related research is more strongly associated with actin biology, cell migration, wound-healing models, and tissue remodeling. The overlap makes the pair easy to discuss together, but overlap is not the same thing as demonstrated synergy.

Recent online discussion reflects exactly this tension. Reddit threads in 2026 repeatedly ask whether adding TB-500 to BPC-157 actually changes outcomes, why the two are called a "Wolverine" stack, and how much of the combination story comes from anecdote versus published research. Those conversations are useful as a map of reader intent, but forum experience is not a substitute for controlled evidence.

The strongest current combination-specific evidence is a 2026 rat Achilles-tendon study. It compared control, BPC-157, TB-500, and combined treatment. The authors found significant biomechanical improvement in the TB-500 group and histological improvements in some treated groups, but the combination did not provide additional benefit compared with either agent alone.

That makes the scientifically honest description of the Wolverine Blend: a commercially defined research combination whose individual components have substantial preclinical literature, but whose combination evidence remains limited.

American Peptides Wolverine Blend Composition and Specifications

According to the current product page, the American Peptides Wolverine Blend has these catalog specifications:

Specification	Current listing
Product	BPC-157 + TB-500 (Wolverine Blend)
Total amount	20 mg
Format	Lyophilized peptide powder
BPC-157	15 amino acids
TB-500	7-amino-acid acetylated fragment
Purity claim	≥99% by HPLC
Identity/testing	HPLC + mass spectrometry
COA	Lot-matched COA available
Current listed price	$195
Volume price, 3-4 units	$181.35 each
Volume price, 5-9 units	$173.55 each
Volume price, 10+ units	$163.80 each
Storage listed	-20°C for lyophilized material
Use designation	Research use only

One practical point is easy to miss: 20 mg is the total blend amount, not 20 mg of BPC-157 plus 20 mg of TB-500. When comparing products, researchers should verify the exact composition and how the supplier defines the total quantity before calculating cost or comparing it with separate vials.

How to Evaluate the Wolverine Blend COA

For analytical procurement, the COA is arguably more important than a headline purity number.

American Peptides currently says the Wolverine Blend is backed by a lot-matched Certificate of Analysis, and its public COA library lists a current certificate for Lot BPCTB20-0803, alongside a superseded older certificate.

A useful COA review should answer several questions:

1. Does the lot number match?

The certificate should correspond to the actual batch being purchased or received. A generic certificate that names the compound but does not identify the relevant lot is weaker documentation than a lot-specific report.

2. What does the identity test show?

Mass spectrometry can support molecular-identity confirmation by measuring mass-to-charge characteristics. For peptides, that is a different question from chromatographic purity.

3. What does HPLC actually tell you?

HPLC separates components chromatographically and is commonly used to assess relative purity. A high HPLC percentage can tell you a great deal about the chromatographic profile, but it does not automatically prove every other possible quality attribute.

4. Is the analytical method clearly stated?

A strong certificate should make it possible to understand what was tested, how it was tested, and what result was obtained. The current American Peptides product page explicitly references HPLC, mass spectrometry, third-party testing, and lot-matched COAs.

5. Are there additional quality controls?

American Peptides currently describes additional testing layers beyond HPLC and mass spectrometry, including endotoxin, sterility, heavy-metal, and batch-consistency testing. These are separate quality questions: a chromatogram is not designed to answer every microbiological or inorganic-contaminant question.

For a broader explanation of COA interpretation, the existing American Peptides BPC-157 research guide is useful background, particularly its emphasis on matching the certificate to the current lot and separating identity testing from purity claims.

HPLC vs Mass Spectrometry for the Wolverine Blend

Researchers evaluating peptide suppliers often see both terms and assume they are interchangeable. They are not.

HPLC is primarily useful for chromatographic separation and purity assessment.

Mass spectrometry is useful for molecular-mass information that can support identity confirmation.

Using both creates a more informative analytical picture than relying on a single number printed on a product page. The American Peptides Wolverine listing explicitly states that its lots are verified using HPLC and mass spectrometry and supported by a lot-matched COA.

The important takeaway is not that either test is "better." It is that they answer different analytical questions.

Current Wolverine Blend Pricing

The current American Peptides list price for the 20 mg Wolverine Blend is $195. The site also displays automatic volume pricing: $181.35 per unit for 3-4, $173.55 for 5-9, and $163.80 for 10 or more.

That creates a useful procurement distinction between catalog price and effective per-unit price.

Quantity	Listed unit price	Displayed reduction
1-2	$195.00	Base price
3-4	$181.35	7%
5-9	$173.55	11%
10+	$163.80	16%

These are the supplier's displayed volume tiers before considering any separate promotional code. Because LOOT10 is advertised as up to 30% off, the exact interaction between the promotion and a particular volume tier should be confirmed in the cart rather than assumed.

How Much Could LOOT10 Save?

The current promotion URL is:

https://www.americanpeptides.us/loot30

Use promo code:

LOOT10

The promotion is described as up to 30% off.

For a simple illustration, a full 30% reduction from the $195 base price would be $58.50, producing a hypothetical $136.50 total before tax or other order-level charges. That is a mathematical example, not a promise that the Wolverine Blend will receive 30% off. The site's wording is "up to 30%," so the actual eligible discount should be verified at checkout.

The same principle applies when comparing volume pricing. A researcher should compare the final cart price rather than adding discounts together manually.

Is the Wolverine Blend Better Than Buying BPC-157 and TB-500 Separately?

There is no universal answer because the choice depends on the experimental design.

A defined combination can make procurement simpler when a project specifically calls for a fixed commercial blend. It also means the two components are supplied together, which can be convenient for combination-oriented experimental work.

Buying the compounds separately provides a cleaner way to vary experimental conditions or attribute an observed result to one component at a time.

That distinction becomes particularly important because the current combination evidence does not demonstrate that the two compounds produce an additive effect. In the 2026 rat study, the combined group did not show additional benefit compared with the individual treatments.

So the better procurement question is not "blend or separate is better?" It is:

Does your research design require a defined combination, or does it require independent control of each variable?

Wolverine Blend vs Individual BPC-157 and TB-500

American Peptides currently lists BPC-157 starting at $60 and TB-500 at $100, while the Wolverine Blend is $195 for 20 mg.

Those numbers cannot be compared as a simple "cheapest per milligram" contest because the product quantities and composition are different.

A sensible comparison should include:

exact sequence or molecular definition
amount of each compound
total amount supplied
lot-specific COA
identity testing
HPLC purity
mass-spectrometry data
third-party testing
storage requirements
volume pricing
promotion eligibility
shipping cost
final checkout price

The existing BPC-157 vs TB-500 research comparison goes deeper into the scientific distinction between the two research traditions and why a simple "which one is better?" ranking is misleading.

Where the Wolverine Blend Fits in the American Peptides Catalog

The Wolverine Blend is part of American Peptides' Peptide Blends category rather than its individual Research Peptides section.

The wider catalog currently lists 73 research compounds across nine categories, including GLP-1 and metabolic products, individual research peptides, peptide blends, liquid sprays, dissolving strips, bioregulators, research bundles, lab supplies, and merchandise.

Within the peptide-blend category, the current catalog also includes CJC-1295 + GHRP-6, CJC-1295 + ipamorelin, GLOW MIX, KLOW BLEND, and tesamorelin + ipamorelin.

That broader context matters because a researcher evaluating American Peptides is not choosing from a one-product store. The appropriate material depends on the actual experimental question, and the supplier's catalog spans several different research areas.

Research-Use-Only Status and the Current Regulatory Picture

American Peptides explicitly states that the Wolverine Blend is supplied for laboratory and research use only, and that it is not a drug, food, supplement, cosmetic, or FDA-approved medicine.

That matters because online discussions frequently blur research materials and personal-use claims.

Current FDA material also underscores the uncertainty around BPC-157 and TB-500. FDA identifies limited safety information for BPC-157 and says that TB-500, described as the thymosin beta-4 fragment LKKTETQ, has potential concerns involving immunogenicity, aggregation and peptide-related impurities, with no identified human exposure data for drug products containing TB-500 in the cited review.

In July 2026, an FDA advisory committee meeting considered BPC-157-related and TB-500-related bulk drug substances in the context of potential inclusion on the 503A bulks list. That regulatory process should not be confused with FDA approval of these substances as medicines.

For content purposes, the safest and most accurate language is therefore to describe the Wolverine Blend as a research material and distinguish preclinical findings from established clinical evidence.

What the Current Research Actually Supports

A balanced summary looks like this:

BPC-157: substantial preclinical interest, including studies of vascular, gastrointestinal and soft-tissue biology, but limited human evidence and no established clinical dosing framework.

TB-500: should be distinguished from full-length thymosin beta-4; the broader Tβ4 literature is much larger than the specific TB-500 fragment literature.

Wolverine combination: current combination-specific evidence includes a 2026 rat Achilles-tendon study, which did not demonstrate an added benefit from combining the two compounds.

Commercial product quality: American Peptides currently lists lot-matched COAs, HPLC and mass-spectrometry verification, third-party testing, and additional testing layers on its site. Those are procurement and analytical claims; they should not be confused with proof of clinical efficacy.

Frequently Asked Questions About the American Peptides Wolverine Blend and LOOT10 What is the American Peptides BPC-157 + TB-500 Wolverine Blend?

It is a 20 mg lyophilized research-peptide blend containing BPC-157 and TB-500. American Peptides lists it at $195 and provides a lot-matched COA.

Does the American Peptides Wolverine Blend have a COA?

Yes. American Peptides states that the blend has lot-matched COA documentation, and its COA library currently lists a certificate for Lot BPCTB20-0803.

How much is the American Peptides Wolverine Blend?

The current displayed price is $195 for 20 mg, with lower automatic volume pricing at higher quantities.

Does the LOOT10 code give 30% off the Wolverine Blend?

LOOT10 is advertised as providing up to 30% off. The exact discount for the Wolverine Blend should be confirmed at checkout because "up to 30%" does not establish that every SKU receives the maximum discount.

Where should I use the American Peptides LOOT10 code?

Start from American Peptides, add the eligible research product to the cart, and enter LOOT10 at checkout. Confirm the actual price reduction before completing the order.

Is the Wolverine Blend the same thing as full-length thymosin beta-4?

No. The American Peptides product page specifies TB-500 as a separate seven-amino-acid fragment, while full-length thymosin beta-4 is a larger protein. Research on one should not automatically be represented as research on the other.

Is there human clinical research on the BPC-157 + TB-500 combination?

Combination-specific human evidence is not established. A 2026 PubMed-indexed study evaluated the combination in rats, not humans, and reported no additional benefit from the combination compared with the individual treatments.

Why are BPC-157 and TB-500 called the Wolverine Blend?

"Wolverine" is an informal nickname used in peptide communities for the pairing of BPC-157 and TB-500. Current online discussions show that the term is common, but the nickname itself is not evidence that the combination is clinically effective.

What should researchers check on a Wolverine Blend COA?

At minimum, verify the lot number, product identity, analytical methods, reported purity, testing date, and whether the certificate matches the current batch. Independent testing and additional quality-control data are useful further checks.

Is the American Peptides Wolverine Blend intended for human use?

No. American Peptides explicitly labels the product for laboratory and research use only and states that it is not intended for human or veterinary consumption.

Final Takeaway: Is the American Peptides Wolverine Blend Worth Considering for Research?

For a researcher specifically looking for a defined BPC-157 + TB-500 research blend, American Peptides offers a straightforward catalog option: 20 mg total material, published analytical specifications, a lot-matched COA, displayed volume pricing, and a current promotion using LOOT10 for up to 30% off.

The more important point is to match the product to the research question. The Wolverine Blend should not be treated as a clinically validated therapy, and the current combination evidence does not justify claiming that BPC-157 and TB-500 are proven to work better together. The 2026 animal study is useful precisely because it puts a limit on the hype: it tested the combination directly and did not find an additive effect.

For researchers who have decided that this specific blend fits their laboratory work, the practical next step is to review the current lot-specific COA, verify the exact catalog quantity, compare the displayed volume tier with the final cart price, and then test LOOT10 through American Peptides to see whether the current promotion produces additional savings.

American Peptides BPC-157 + TB-500 Wolverine Blend: LOOT10 Pricing, Composition, COA and Catalog Guide

Post a Reply